SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Commerzbank AG (CRZBF) trades at a trailing P/E of 18.0, forward P/E of 13.7. Trailing earnings yield is 5.55%, forward earnings yield 7.29%. PEG 1.57.
Criteria proven by this page:
- VALUE (75/100, Pass) — P/E is below market average (18.0); earnings yield beats bond yields (5.55%).
- Forward P/E 13.7 (down from trailing 18.0) — analysts expect earnings to grow, which would improve the valuation.
- PEG Ratio 1.57 — between 1.0–2.0 indicates moderate valuation relative to growth.
- Trailing Earnings Yield 5.55% — exceeds typical bond yields (~4.3%), making equity attractive vs fixed income. Forward yield improves to 7.29% as earnings recover.
Overall SharesGrow Score: 78/100 with 4/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
75/100
Price-to-Earnings & upside
Proven by this page
~
HEALTH
50/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — CRZBF
Valuation Multiples
P/E (TTM)18.0
Forward P/E13.7
PEG Ratio1.57
Forward PEG0.43
P/B Ratio0.00
P/S Ratio4.24
EV/EBITDA0.0
Per Share Data
EPS (TTM)$2.32
Forward EPS (Est.)$3.05
Book Value / Share$0.00
Revenue / Share$9.87
FCF / Share$0.00
Yields & Fair Value
Earnings Yield5.55%
Forward Earnings Yield7.29%
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$0.22 |
$8.87B |
$279M |
3.1% |
| 2017 |
$0.12 |
$8.92B |
$156M |
1.7% |
| 2018 |
$0.69 |
$8.62B |
$865M |
10% |
| 2019 |
$0.51 |
$8.85B |
$644M |
7.3% |
| 2020 |
$-2.29 |
$8.77B |
$-2.87B |
-32.7% |
| 2021 |
$0.23 |
$9.65B |
$430M |
4.5% |
| 2022 |
$0.99 |
$8.67B |
$1.44B |
16.6% |
| 2023 |
$1.63 |
$9.92B |
$2.22B |
22.4% |
| 2024 |
$2.08 |
$25.25B |
$2.68B |
10.6% |
| 2025 |
$2.32 |
$11.13B |
$2.62B |
23.6% |
